CE-marked multimodal prediction model for preeclampsia risk stratification that combines biomarker analysis (sFlt-1/PlGF) with clinical data and digital patient diary functionality. Supports early risk identification in pregnant women through integrated home-based data entry.
Manufactured by
NeoPredics AG (Germany)
Regensburg, Germany
NeoPredics is transforming clinical decision support, delivering personalized solutions that optimize care for women and children. Our cutting-edge technology empowers clinicians to predict health risks earlier, facilitating timely, sometimes life-saving interventions for mothers and their babies.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
JUMPER MEDICAL
China · 2 relevant products
Shenzhen Create Medical Technology Co., Ltd.
China · 1 relevant product
Mediwhale Inc.
South Korea · 1 relevant product
18 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →8 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 34 closest product alternatives
JUMPER MEDICAL · China
Digital system for collection, management, and analysis of prenatal screening data. Integrates clinical examination findings with maternal health records.
Shenzhen Create Medical Technology Co., Ltd. · China
Multi-omics technology platform for precision prediction and diagnosis of diabetes with cardiovascular disease. Enables genetic risk stratification and clinical decision support for high-risk populations.
Mediwhale Inc. · South Korea
Integrated AI platform for early detection and personalized risk assessment of cardiometabolic diseases through retinal imaging analysis. Designed for seamless integration into hospital and clinic information systems globally.
31 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products